Back

Genetic depletion of smooth muscle cells (SMCs) from atheroprogression fundamentally reshapes murine brachiocephalic artery (BCA) lesions

29 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Atherosclerosis: mechanisms, imaging, and therapeutics Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Alejandro Martinez Navarro

Clinic of the University of Munich Grosshadern, Munich (Germany)

6 More presentations in this session

Presentation thumbnail
Nanotheranostics alleviate vulnerable atherosclerotic plaques through lipid-specific photoacoustic imaging and hypoxic microenvironment modulation
Mr Z. Chen (Hangzhou, CN)
Abstract Slides
Presentation thumbnail
CCR2-Overexpressing hydrogelated macrophages facilitate targeted lipid clearance and immunomodulation in atherosclerosis treatment
Professor C. Yan (Shenyang, CN)
Abstract Slides
Presentation thumbnail
PI3 kinase-α protects against vascular inflammation, atherosclerosis, and plaque instability by regulating the biology of vascular smooth muscle cells.
Doctor M. Zierden (Cologne, DE)
Abstract Slides
Presentation thumbnail
The asialoglycoprotein receptor 1, the glycome, and proteome associate with coronary atherosclerosis progression on serial photon-counting coronary computed tomography angiography
Doctor N. Wattchow (Adelaide, AU)
Abstract Slides
Presentation thumbnail
Elevated remnant cholesterol explains a substantial part of excess cardiovascular risk in the metabolic syndrome
Doctor K. Hvid (Herlev, DK)
Abstract Slides

Access the full session

Session thumbnail
Atherosclerosis: mechanisms, imaging, and therapeutics

The Event

Event poster

ESC Congress 2026

29 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Smooth muscle cell-specific deletion of S100A4 reroutes smooth muscle cell fate and modifies the inflammatory status of murine atherosclerotic lesions
30 April 2022
thumbnail
Congress Presentation
Exploring adventitial pericyte dysfunction and MEK/ERK signalling as therapeutic targets in thoracic aortic aneurysm
1 September 2025
thumbnail
Congress Presentation
Active-target liposomal drug shows significant atherosclerotic plaque regression effect: a proof-of-concept phase 1b/2a clinical trial
1 September 2025
thumbnail
Congress Presentation
Deficiency of myeloid prolyl hydroxylase domain proteins aggravates atherogenesis via macrophage apoptosis and paracrine fibrotic signaling
29 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources